Insulet Corporation announced results from the first pivotal study of the Omnipod 5 automated insulin delivery system that bode well for its expected launch of the device in the first half of 2021.
The Omnipod 5 is the world’s first tubeless wearable system that continuously adapts insulin delivery based on glucose levels and...